Protective capacity and epitope specificity of CD8+ T cells responding to lethal West Nile virus infection

European Journal of Immunology

Volumn 37, Issue 7, 2007, Pages 1855-1863

  Brien, James D ^a   Uhrlaub, Jennifer L ^a   Nikolich Žugich, Janko ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

CD8+ T cells; Infectious diseases; Virology; West Nile virus

Indexed keywords

EPITOPE; STRUCTURAL PROTEIN; VIRUS PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; INFECTION RISK; INFECTION SENSITIVITY; LYMPHOCYTE TRANSFER; MALE; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; IMMUNODOMINANT EPITOPES; MALE; MICE; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; WEST NILE FEVER;

EID: 34447557656     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737196     Document Type: Article

References (32)

1. Brinton, M. A., The molecular biology of West Nile Virus: a new invader of the western hemisphere. Annu. Rev. Microbiol. 2002. 56: 371-402.
2. Campbell, G. L., Marfin, A. A., Lanciotti, R. S. and Gubler, D. J., West Nile virus. Lancet Infect. Dis. 2002. 2: 519-529.
3. Anderson, J. F., Andreadis, T. G., Vossbrinck, C. R., Tirrell, S., Wakem, E. M., French, R. A., Garmendia, A. E. and Van Kruiningen, H. J., Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut. Science 1999. 286: 2331-2333.
4. Lanciotti, R. S., Roehrig, J. T., Deubel, V., Smith, J., Parker, M., Steele, K., Crise, B. et al., Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999. 286: 2333-2337.
5. Anonymous, West Nile Virus. Centers for Disease Control 2003
6. Marfin, A. A., Petersen, L. R., Eidson, M., Miller, J., Hadler, J., Farello, C., Werner, B. et al., Widespread West Nile virus activity, eastern United States 2000. Emerg. Infect. Dis. 2001. 7: 730-735.
7. Nash, D., Mostashari, F., Fine, A., Miller, J., O'Leary, D., Murray, K., Huang, A. et al., The outbreak of West Nile virus infection in the New York City area in 1999. N. Engl. J. Med. 2001. 344: 1807-1814.
8. Chambers, T. J. and Diamond, M. S., Pathogenesis of flavivirus encephalitis. Adv. Virus Res. 2003. 60: 273-342.
9. Hayes, C., West Nile Virus: Uganda. Ann. N.Y. Acad. Sci. 2001. 951: 25.
10. Mostashari, F., Bunning, M. L., Kitsutani, P. T., Singer, D. A., Nash, D., Cooper, M. J., Katz, N. et al., Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001. 358: 261-264.
11. + T cells in control of West Nile virus infection. J. Virol. 2004. 78: 8312-8321.
12. + T cells mediate recovery and immunopathology in West Nile virus encephalitis. J. Virol. 2003. 77: 13323-13334.
13. Lin, M. S., Gharia, M. A., Swartz, S. J., Diaz, L. A. and Giudice, G. J., Identification and characterization of epitopes recognized by T lymphocytes and autoantibodies from patients with herpes gestationis. J. Immunol. 1999. 162: 4991-4997.
14. Rock, K. L., Gamble, S. and Rothstein, L., Presentation of exogenous antigen with class I major histocompatibility complex molocules. Science 1990. 249: 918-921.
15. Kageyama, S., Tsomides, T. J., Sykulev, Y. and Eisen, H. N., Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses. J. Immunol. 1995. 154: 567-576.
16. Purbhoo, M. A., Irvine, D. J., Huppa, J. B. and Davis, M. M., T cell killing does not require the formation of a stable mature immunological synapse. Nat. Immunol. 2004. 5: 524-530.
17. Falk, K., Rotzschke, O., Stevanovic, S., Jung, G. and Rammensee, H.-G., Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991. 351: 290-296.
18. Kaech, S. M., Tan, J. T., Wherry, E. J., Konieczny, B. T., Surh, C. D. and Ahmed, R., Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 2003. 4: 1191-1198.
19. Engle, M. J. and Diamond, M. S., Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice. J. Virol. 2003. 77: 12941-12949.
20. Diamond, M. S., Shrestha, B., Mehlhop, E., Sitati, E. and Engle, M., Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol. 2003. 16: 259-278.
21. King, N., Shrestha, B. and Kesson, A., Immune modulation by flaviviruses. Adv. Virus Res. 2003. 60: 121-154.
22. Wang, T., Town, T., Alexopoulou, L., Anderson, J. F., Fikrig, E. and Flavell, R. A., Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 2004. 10: 1366-1373.
23. Diamond, M., Shrestha, B., Marri, A., Mahan, D. and Engle, M., B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J. Viral. 2003. 44: 2578-2586.
24. Mehlhop, E., Whitby, K., Oliphant, T., Marri, A., Engle, M. and Diamond, M. S., Complement activation is required for induction of a protective antibody response against West Nile virus infection. J. Virol. 2005. 79: 7466-7477.
25. Diamond, M. S., Evasion of innate and adaptive immunity by flaviviruses. Immunol. Cell Biol. 2003. 81: 196-206.
26. Lobigs, M., Mullbacher, A., Wang, Y., Pavy, M. and Lee, E., Role of type I and type II interferon responses in recovery from infection with an encephalitic flavivirus. J. Gen. Virol. 2003. 84: 567-572.
27. Wang, T., Scully, E., Yin, Z., Kim, J. H., Wang, S., Yan, J., Mamula, M. et al., IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection. J. Immunol. 2003. 171: 2524-2531.
28. Kesson, A., Blanden, R. V. and Mullbacher, A., The primary in vivo murine cytotoxic T-cell response to the flavivirus, West Nile. J. Gen. Virol. 1987. 68: 2001-2006.
29. + T cells require perforin to clear West Nile virus from infected neurons. J. Virol. 2006. 80: 119-129.
30. Jameson, S. C. and Bevan, M. J., Dissection of MHC and TCR contact residues in a Kb restricted ovalbumin peptide and an assessment of the predictive power of MHC binding motifs. Eur. J. Immunol. 1992. 22: 2663.
31. Huard, R., Dyall, R. and Nikolic-Žugic, J., The critical role of a solvent-exposed residue of an MHC class I-restricted peptide in MHC-peptide binding. Int. Immunol. 1997. 9: 1701-1707.
32. Dyall, R., Vasovic, L. V., Molano, A. and Nikolic-Zugic, J., CD4-independent in vivo priming of murine CTLs by optimal MHC class I-restricted peptides derived from HIV and other pathogens. Int. Immunol. 1995. 7: 1205-1212.